Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arizona Sci-Tech Gazette.
Press releases published on September 5, 2025
Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
GlobeNewswire
·
September 5, 2025
SAN DIEGO and SUZHOU, China, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ADG126 will be highlighted …
iFLYTEK Launches AINOTE Air 2 in Europe: Redefining Productivity with AI-Powered E-Ink Technology
GlobeNewswire
·
September 5, 2025
FRANKFURT, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iFLYTEK today announced the launch of its latest E-Ink tablet, AINOTE Air 2, in the European market through joint marketing with Joybuy. With this launch, the Air 2 introduces German and Spanish system …
Robot Consulting Co., Ltd. Engages Former bitFlyer Holdings CEO Masaaki Seki as to Advise on Ethereum Investment Strategy and Finance
GlobeNewswire
·
September 5, 2025
Tokyo, Japan, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Robot Consulting Co., Ltd. (Nasdaq: LAWR) (the “Company” or “Robot Consulting”), a Japanese platform service provider focusing on human resource solutions with an intention to expand into legal technology …
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
GlobeNewswire
·
September 5, 2025
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~ ~Subgroups - including Black or African American adults, older adults, women, and …
Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)
GlobeNewswire
·
September 5, 2025
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to commence in H2 2025; Topline data anticipated in Q1 2026 Continued progress toward Phase 2 IND …
Orbit International Reports Consolidated Bookings of Approximately $2,400,000 for Month of August
GlobeNewswire
·
September 5, 2025
HAUPPAUGE, N.Y., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that for the month of August 2025, consolidated bookings …
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
GlobeNewswire
·
September 5, 2025
FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod …
Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025
GlobeNewswire
·
September 5, 2025
$10.7 Million Repaid Year to Date and $32.7 Million Since September 2024 Obligation Debt Reduction Initiatives Adding Material Benefit to Net Income and Shareholders’ Equity SEATTLE, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: …
Tiziana Life Sciences Announces Purchase of Shares by Chairman
GlobeNewswire
·
September 5, 2025
BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
24/7 Market News: Kraig Labs Fibers are 5X Stronger Than Steel, Tougher than Kevlar, and Biodegradable
GlobeNewswire
·
September 5, 2025
DENVER, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the …
Lowkick Studio Launches $SHARDS as WorldShards Expands to Global Audiences
GlobeNewswire
·
September 5, 2025
Abu Dhabi, UAE, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Lowkick Studio has officially announced the launch of the $SHARDS token, the core of its upcoming Web3 MMORPG, WorldShards. The token generation event (TGE) coincides with listings on top-tier exchanges, …
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
GlobeNewswire
·
September 5, 2025
ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …
Geotab atinge 5 milhões de veículos conectados globalmente e reforça liderança em telemática
GlobeNewswire
·
September 5, 2025
SÃO PAULO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- A Geotab anunciou a conquista de um novo marco: alcançou a marca de mais de 5 milhões de veículos conectados globalmente, reforçando sua liderança em telemática e soluções para o setor de transportes. O …
Youxin Technology Ltd Announces Pricing of $6.0 Million Underwritten Public Offering
GlobeNewswire
·
September 5, 2025
GUANGZHOU, CHINA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (NASDAQ: YAAS) (the “Company”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their …
Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future
GlobeNewswire
·
September 5, 2025
Frankfurt, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Blocksize, a German-based DeFi infrastructure provider, is calling attention to the hidden fees of custodial staking platforms, which quietly erode yields, undermine governance, and place long-term …
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
GlobeNewswire
·
September 5, 2025
EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. …
NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board
GlobeNewswire
·
September 5, 2025
Vancouver, B.C. , Sept. 05, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …